'
Hikal conducted conference call on 29 May 2023 to discuss the financial results and performance of the company for the quarter ended March 2023. Mr. Sameer Hiremath – Managing Director, Mr. Anish Swadi – Senior President, Business Transformation, Mr. Kuldeep Jain – Chief Financial Officer, Mr. Manoj Mehrotra – President, Pharmaceuticals Business and Mr. Vimal Kulshrestha – President, Crop Protection Business of the company addressed the call.
Highlights of the Concall
- Revenue recorded an increase of 9% YoY and stood at Rs 545 crore in Q4FY23 primarily driven by the recovery in the pharma business, change in product mix and increased demand of select products
- EBITDA stood at Rs 90 crore up by 48% in Q4FY23 on YoY basis. Sequential QoQ recovery in margins was on back of softening of raw material prices and several operational improvement initiatives Enhanced efficiencies on account of ongoing business excellence programs across value chain.
Pleaselogin & subscribe to view the full report.
More Reports
|
|